Tyra Biosciences, Inc.
TYRA
$12.12
$0.423.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 296.27M | 318.94M | 341.44M | 360.13M | 373.80M |
| Total Receivables | 1.70M | 1.80M | 2.00M | 1.90M | 1.90M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.18M | 3.82M | 4.02M | 3.58M | 2.88M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 302.16M | 324.57M | 347.46M | 365.61M | 378.57M |
|
|
|||||
| Total Current Assets | 302.16M | 324.57M | 347.46M | 365.61M | 378.57M |
| Net Property, Plant & Equipment | 7.24M | 7.47M | 7.72M | 7.98M | 8.19M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.11M | 11.44M | 8.38M | 7.01M | 5.69M |
| Total Assets | 321.50M | 343.48M | 363.56M | 380.59M | 392.46M |
|
|
|||||
| Total Accounts Payable | 2.25M | 2.50M | 590.00K | 1.17M | 1.58M |
| Total Accrued Expenses | 11.08M | 11.32M | 13.59M | 10.81M | 8.42M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 441.00K | 426.00K | 412.00K | 398.00K | 383.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 13.77M | 14.25M | 14.59M | 12.37M | 10.38M |
|
|
|||||
| Total Current Liabilities | 13.77M | 14.25M | 14.59M | 12.37M | 10.38M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.58M | 5.70M | 5.81M | 5.92M | 6.02M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 3.00K | 11.00K | 20.00K |
| Total Liabilities | 19.35M | 19.94M | 20.41M | 18.30M | 16.42M |
|
|
|||||
| Common Stock & APIC | 609.27M | 602.30M | 593.69M | 586.28M | 577.95M |
| Retained Earnings | -307.56M | -279.46M | -251.31M | -225.74M | -201.72M |
| Treasury Stock & Other | 436.00K | 688.00K | 770.00K | 1.75M | -184.00K |
| Total Common Equity | 302.15M | 323.53M | 343.15M | 362.29M | 376.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 302.15M | 323.53M | 343.15M | 362.29M | 376.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 302.15M | 323.53M | 343.15M | 362.29M | 376.04M |
|
|
|||||